Results 171 to 180 of about 16,430 (217)

Comparative Evaluation of Lipid Profile, C-Reactive Protein and Paraoxonase-1 Activity in Dogs with Inflammatory Protein-Losing Enteropathy and Healthy Dogs. [PDF]

Animals (Basel)
Gianella P, Cagnasso F, Giordano A, Borrelli A, Bottero E, Bruno B, Ferriani R, Borella F, Meazzi S, Scavone D, Paltrinieri S.   +10 more
europepmc   +1 more source

Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial. [PDF]

Osong Public Health Res Perspect
Ildarabadi A, Vahid-Dastjerdi M, Ghorbanpour M, Mousavi A, Meshkani M, Yekaninejad M, Saedisomeolia A.   +6 more
europepmc   +1 more source

Paraoxonase-1 And Coronary Heart Diseases

Marmara Medical Journal, 2010
openaire   +1 more source

The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial. [PDF]

Sci Rep
Matin SS, Shidfar F, Naderi N, Amin A, Hosseini-Baharanchi FS, Dehnad A.   +5 more
europepmc   +1 more source

Paraoxonase and arylesterase activity of paraoxonase 1 and oxidative stress parameters in cervical intraepithelial neoplasia. [PDF]

Biochem Med (Zagreb)
Butorac D, Ćelap I, Kačkov Maslać S, Miletić T, Tomašković AH, Turčić P, Rašić D, Stojanović I, Rajković MG.   +8 more
europepmc   +1 more source

Corinthian Currants Promote the Expression of Paraoxonase-1 and Enhance the Antioxidant Status in Serum and Brain of 5xFAD Mouse Model of Alzheimer's Disease. [PDF]

Biomolecules
Lymperopoulos D, Dedemadi AG, Voulgari ML, Georgiou E, Dafnis I, Mountaki C, Panagopoulou EA, Karvelas M, Chiou A, Karathanos VT, Chroni A.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Targeting paraoxonase-1 in atherosclerosis

Expert Opinion on Therapeutic Targets, 2013
Paraoxonase-1 (PON1) is a Ca(2+) dependent, high-density lipoprotein-associated lactonase which is capable of retarding/inhibiting low-density lipoprotein (LDL) oxidation. LDL oxidation is believed to be central to the initiation and progression of atherosclerosis, therefore, PON1 is considered to be atheroprotective.Relevant literature on PON1 was ...
Mike, Mackness, Bharti, Mackness
openaire   +2 more sources

Paraoxonase 1 and homocysteine metabolism

Amino Acids, 2012
Paraoxonase 1 (PON1), a component of high-density lipoprotein (HDL), is a calcium-dependent multifunctional enzyme that connects metabolisms of lipoproteins and homocysteine (Hcy). Both PON1 and Hcy have been implicated in human diseases, including atherosclerosis and neurodegeneration.
Joanna, Perła-Kaján, Hieronim, Jakubowski   +1 more
openaire   +2 more sources

Paraoxonase 1 and HDL maturation

Clinica Chimica Acta, 2015
Understanding the kinetics and function of paraoxonase 1 (PON1) is becoming an important issue in atherosclerosis. Low PON1 activity has been consistently linked with an increased risk of major cardiovascular events in the setting of secondary prevention of coronary artery disease.
Alejandro, Gugliucci, Teresita, Menini
openaire   +2 more sources